- Biopharma’s 2025 industry pay report; Parabilis sets industry record IPO; and moreWelcome back to Endpoints Weekly! This week, we opened nominations for our eighth annual Women in Biopharma report. We’re looking to profile 20 scientists, executives, founders and other enterprisi…Endpoints · 1mo ago↗ source
- Merck brings Welireg-Keytruda combo to treat kidney cancerMerck’s Welireg and Keytruda combination won approval as an adjuvant treatment for kidney cancer patients after surgery to remove all or part of the organ. The combination was approved Friday for…Endpoints · 1mo ago↗ source
- Amgen and the FDA want two different outcomes for Tavneos. What will patients do?Amgen has asked the FDA to review evidence that its drug Tavneos (avacopan), which treats a rare form of vasculitis, is worth keeping on the market, as the future of the drug remains in flux. ...